These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1471252)

  • 1. Continued monitoring for human immunodeficiency virus type 2 infections in California.
    Busch MP; Tobler L; Schable C; Petersen L
    Transfusion; 1992; 32(9):873. PubMed ID: 1471252
    [No Abstract]   [Full Text] [Related]  

  • 2. Limited evidence of human immunodeficiency virus type 2 (HIV-2) infection in sera from blood donors showing positive ELISA but negative or indeterminate western blot reactivity for HIV-1 infection.
    Chattopadhya D; Kumari S; Verghese T
    J Commun Dis; 1991 Sep; 23(3):206-7. PubMed ID: 1812169
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroprevalence of human immunodeficiency virus among blood donors in a rural Ethiopian hospital.
    Ramos JM; Reyes F; Tesfamariam A
    Trop Doct; 2008 Jul; 38(3):182-3. PubMed ID: 18628556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1)].
    Machado AA; Hirsch I; Figueiredo JF; Martinez R; de Freitas-Silva G; Chermann JC; Covas DT
    Rev Soc Bras Med Trop; 1996; 29(6):615-7. PubMed ID: 9011891
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type 1 and 2.
    Ng KP; Saw TL; Baki A; He J; Singh N; Lyles CM
    Int J STD AIDS; 1999 Jun; 10(6):401-4. PubMed ID: 10414883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid test for distinguishing HIV-1 and HIV-2.
    De Cock KM; Maran M; Kouadio JC; Porter A; Lafontaine MF; Gnaore E; Bretton R; George JR
    Lancet; 1990 Sep; 336(8717):757. PubMed ID: 1975933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serology of HIV infection].
    Gschnait F; Schwarz T; Hobisch G; Schmidt BL
    Hautarzt; 1989 Dec; 40(12):745-51. PubMed ID: 2695498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern serologic diagnosis of HIV 1 and HIV 2 infection].
    Mertens T
    Verh Dtsch Ges Inn Med; 1991; 97():375-81. PubMed ID: 1808918
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening of blood donations for HIV-1 antibody: 1985-1991.
    Gunson HH; Rawlinson VI
    CDR (Lond Engl Rev); 1991 Dec; 1(13):R144-6. PubMed ID: 1669759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the Abbott recombinant HIV-1/HIV-2 enzyme immunoassay for the detection of HIV antibodies.
    Gershy-Damet GM; Kodjo M; Benoit S
    AIDS; 1990 Jan; 4(1):87-8. PubMed ID: 2156529
    [No Abstract]   [Full Text] [Related]  

  • 11. [Human immunodeficiency virus type 1, type 2].
    Handa N
    Nihon Rinsho; 1999 Nov; 57 Suppl():372-8. PubMed ID: 10635861
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city.
    Savarit D; De Cock KM; Schutz R; Konate S; Lackritz E; Bondurand A
    BMJ; 1992 Aug; 305(6852):498-502. PubMed ID: 1327367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Difficulties of investigation of antibodies against human immunodeficiency virus type 2 using ELISA].
    Soriano Vázquez V; Ribera Crusafont A; Tor Aquilera J; Muga Bustamante R
    Med Clin (Barc); 1988 Oct; 91(14):556-7. PubMed ID: 3216748
    [No Abstract]   [Full Text] [Related]  

  • 14. No evidence for HIV-2 infection in Uganda.
    Downing RG; Biryahwaho B
    Lancet; 1990 Dec; 336(8729):1514-5. PubMed ID: 1979128
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring blood donors for HIV-2 infection by testing anti-HIV-1 reactive sera.
    Busch MP; Petersen L; Schable C; Perkins H
    Transfusion; 1990 Feb; 30(2):184-7. PubMed ID: 1968296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusually strong, but transient, nonspecific human immunodeficiency virus types 1 and 2 antibody reactivity.
    Kiely P; Miller K; Denham-Ricks P; Kebede M
    Transfusion; 2008 Jul; 48(7):1521-2. PubMed ID: 18651910
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of iatrogenic human immunodeficiency virus infection through transfusion of blood tested by inappropriately stored or expired rapid antibody assays in a Zambian hospital.
    Consten EC; van der Meer JT; de Wolf F; Heij HA; Henny PC; van Lanschot JJ
    Transfusion; 1997 Sep; 37(9):930-4. PubMed ID: 9308640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current risk of HIV infection by blood transfusions].
    Braun RW
    Hautarzt; 1989 Jul; 40(7):461. PubMed ID: 2759863
    [No Abstract]   [Full Text] [Related]  

  • 19. [HIV-1 and HIV-2 coinfection or cross reaction?].
    Calderón E; Corzo JE; Pineda JA; Leal M
    Med Clin (Barc); 1990 Mar; 94(11):437-8. PubMed ID: 2377017
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of indirect immunofluorescence and membrane fluorescence assays for the differentiation of antibodies to human immunodeficiency virus types 1 and 2.
    Gallo D; Hoffman MN; Yeh ET; George JR; Hanson CV
    J Clin Microbiol; 1992 Sep; 30(9):2275-8. PubMed ID: 1328285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.